Valliance Capital

Valliance Capital is a private investment firm specializing in private equity and venture capital investments across various sectors in the United States and China. The firm focuses on early-stage, growth, and late-stage investments, targeting companies in industries such as healthcare, technology, consumer goods, education, energy, financial services, media, telecommunications, transportation, real estate, retail, manufacturing, agriculture, hospitality, and logistics. Valliance Capital seeks to partner with innovative and high-growth companies to drive value creation and long-term success.

The firm's investment strategy involves a comprehensive approach, combining detailed research with a disciplined investment process to select portfolio companies. Valliance Capital provides a vertically integrated platform that includes real estate acquisition, financing, asset management, construction management, tax strategy, design and branding, property management, and redevelopment. This integrated approach allows the firm to add value at every stage of the investment lifecycle, from initial acquisition to eventual exit.

Valliance Capital has a track record of investing in diverse sectors, demonstrating its ability to identify and capitalize on opportunities across various industries. The firm's portfolio includes companies such as Dingdang Kuaiyao, a China-based drug delivery service, and Broncus Technologies, a medical device company. These investments reflect Valliance Capital's commitment to supporting innovative companies that are poised for growth and success in their respective markets.